Zobrazeno 1 - 10
of 27
pro vyhledávání: '"cysteine-rich intestinal protein 1"'
Autor:
Hong‐Yu He, Li Hu
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 38, Iss 1, Pp 49-58 (2022)
Abstract The present study aimed to explore the expression and clinical significance of cysteine‐rich intestinal protein 1 (CRIP1) mRNA in the serum of patients with hepatocellular carcinoma (HCC). Reverse transcription polymerase chain reaction (R
Externí odkaz:
https://doaj.org/article/26d1f8d8ba944cffbcccba1c7fa4d2db
Autor:
Lanzhi Zhang, Rui Zhou, Weibin Zhang, Xueqing Yao, Weidong Li, Lijun Xu, Xuegang Sun, Liang Zhao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Abstract Background Cysteine-rich intestinal protein 1 (CRIP1) is highly expressed in human intestine and aberrantly expressed in several types of tumor. However, studies on CRIP1 are limited and its role on tumor development and progression remains
Externí odkaz:
https://doaj.org/article/c29e8453bcaf4f1e8909fb2d989c6692
Publikováno v:
Cellular Physiology and Biochemistry, Vol 44, Iss 3, Pp 897-906 (2017)
Background/Aims: Cysteine-rich intestinal protein 1 (CRIP1), a member of the LIM/double zinc finger protein family, is abnormally expressed in several tumour types. However, few data are available on the role of CRIP1 in cancer. In the present study,
Externí odkaz:
https://doaj.org/article/5a80cd4db2f64c5fa330f09bfaec6f74
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lijun Xu, Liang Zhao, Rui Zhou, Weibin Zhang, Xuegang Sun, Weidong Li, Lanzhi Zhang, Xueqing Yao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
Background Cysteine-rich intestinal protein 1 (CRIP1) is highly expressed in human intestine and aberrantly expressed in several types of tumor. However, studies on CRIP1 are limited and its role on tumor development and progression remains controver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::368fc6e42de0fd096685bcdd8f24872c
http://link.springer.com/article/10.1186/s13046-019-1117-z
http://link.springer.com/article/10.1186/s13046-019-1117-z
Autor:
Hong-Yu He, Li Hu
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 38, Iss 1, Pp 49-58 (2022)
The present study aimed to explore the expression and clinical significance of cysteine‐rich intestinal protein 1 (CRIP1) mRNA in the serum of patients with hepatocellular carcinoma (HCC). Reverse transcription polymerase chain reaction (RT‐PCR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6430a48e5a9467b9f0bf8b90ff5828
https://pubmed.ncbi.nlm.nih.gov/34585826
https://pubmed.ncbi.nlm.nih.gov/34585826
Publikováno v:
Cellular Physiology and Biochemistry, Vol 44, Iss 3, Pp 897-906 (2017)
Background/Aims: Cysteine-rich intestinal protein 1 (CRIP1), a member of the LIM/double zinc finger protein family, is abnormally expressed in several tumour types. However, few data are available on the role of CRIP1 in cancer. In the present study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8479d7158ce50b77274ff09a5947525f
https://www.karger.com/Article/FullText/485357
https://www.karger.com/Article/FullText/485357
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients
Autor:
Gernot Jundt, Daniel Baumhoer, Benjamin Balluff, Michaela Nathrath, Stephanie Zillmer, Sandra Rauser, Mareike Elsner, Axel Walch, Cédrik Schoene, Stefan S. Bielack, Jan Smida
Publikováno v:
Oncotarget
Oncotarget 2, 970-975 (2011)
Europe PubMed Central
Oncotarget 2, 970-975 (2011)
Europe PubMed Central
Daniel Baumhoer 1,2,* , Mareike Elsner 3,* , Jan Smida 2,4 , Stephanie Zillmer 2 , Sandra Rauser 3 , Cedrik Schoene 3 , Benjamin Balluff 3 , Stefan Bielack 5 , Gernot Jundt 1 , Axel Walch 3,# , and Michaela Nathrath 2,4,# 1 Bone Tumor Reference Cente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5252bdb712d0d3451bed9d392dd7fb2
http://europepmc.org/articles/PMC3282102
http://europepmc.org/articles/PMC3282102